- Home
- GDTC vs PIII Comparison
GDTC vs PIII Comparison
Compare GDTC & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- PIII
- Stock Information
- Founded
- GDTC 2018
- PIII 2015
- Country
- GDTC Singapore
- PIII United States
- Employees
- GDTC N/A
- PIII N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- GDTC Health Care
- PIII Health Care
- Exchange
- GDTC Nasdaq
- PIII Nasdaq
- Market Cap
- GDTC 33.4M
- PIII 33.2M
- IPO Year
- GDTC 2023
- PIII N/A
- Fundamental
- Price
- GDTC $2.37
- PIII $0.20
- Analyst Decision
- GDTC Buy
- PIII Buy
- Analyst Count
- GDTC 1
- PIII 3
- Target Price
- GDTC $5.00
- PIII $2.38
- AVG Volume (30 Days)
- GDTC 24.9K
- PIII 429.8K
- Earning Date
- GDTC 01-01-0001
- PIII 11-12-2024
- Dividend Yield
- GDTC N/A
- PIII N/A
- EPS Growth
- GDTC N/A
- PIII N/A
- EPS
- GDTC N/A
- PIII N/A
- Revenue
- GDTC $330,254.00
- PIII $1,476,630,000.00
- Revenue This Year
- GDTC $14.71
- PIII $21.45
- Revenue Next Year
- GDTC N/A
- PIII N/A
- P/E Ratio
- GDTC N/A
- PIII N/A
- Revenue Growth
- GDTC N/A
- PIII 25.38
- 52 Week Low
- GDTC $1.20
- PIII $0.19
- 52 Week High
- GDTC $5.50
- PIII $1.78
- Technical
- Relative Strength Index (RSI)
- GDTC 45.29
- PIII 33.57
- Support Level
- GDTC $2.43
- PIII $0.19
- Resistance Level
- GDTC $3.00
- PIII $0.23
- Average True Range (ATR)
- GDTC 0.41
- PIII 0.02
- MACD
- GDTC -0.03
- PIII 0.00
- Stochastic Oscillator
- GDTC 21.60
- PIII 16.92
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.